Bernie brings a wealth of corporate experience to Artrya, including 37 years in private and ASX listed companies, spending the majority of that time in the role of Managing Director.
Bernie was Managing Director of the top ASX listed company Imdex Limited (Imdex) for 20 years, retiring in July 2020. During that time, Imdex’s revenue grew from approximately $20m per annum in Australia to in excess of $270m per annum, generated from sales from over 100 countries. In that period the market capitalisation of Imdex grew from below $10m to over $600m and now exceeds $800m. Significantly in excess of 60% of revenue was generated from outside Australia.
His vision is for Artrya to become the global standard in non-invasive artificial intelligence and machine learning to diagnose and treat coronary heart disease. Coronary heart disease is the leading cause of death in the world and Artrya can have a substantial positive impact on lowering this death rate. Artrya’s technology is truly disruptive in an area in which technology advances in the past decades have been minimal.
Bernie holds a Bachelor of Business in Accounting, is a qualified Chartered Accountant, and a fellow of the Australian Institute of Company Directors (FAICD).